# Debate Matchup Judgment Report

**GLM-5.3 (high)** vs **Grok 4.7 (high)**

- Paired result: **Tie**
- Mean entertainment: `7.50 / 10`
- Judge decisions: `6` across two side-swapped debates

**Motion:** Health systems should permit and reimburse AI-assisted clinical documentation and triage only if models meet publicly reported accuracy and bias benchmarks.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0624__glm-5-3-high__grok-4.7-high__s0__tpl_placement_active_20260813a.md): PRO = **GLM-5.3 (high)**, CON = **Grok 4.7 (high)**
- [Debate B transcript](../../../transcripts/prop_0624__grok-4.7-high__glm-5-3-high__s1__tpl_placement_active_20260813a.md): PRO = **Grok 4.7 (high)**, CON = **GLM-5.3 (high)**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_20260923_finala.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0624__glm-5-3-high__grok-4.7-high__s0__tpl_placement_active_20260813a.md)
- Roles: PRO = **GLM-5.3 (high)**, CON = **Grok 4.7 (high)**
- Judged result: Split `2-1` for **Grok 4.7 (high)**.
- Entertainment scores: `7`, `7`, `8`
- Mean signed raw margin (PRO+): `-0.67`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Kimi K2.6 | A = GLM-5.3 (high) (PRO); B = Grok 4.7 (high) (CON) | GLM-5.3 (high) | +1.5 | +1.70 | 7.0 |
| Muse Spark 1.1 (high) | A = Grok 4.7 (high) (CON); B = GLM-5.3 (high) (PRO) | Grok 4.7 (high) | -1.5 | -1.59 | 7.0 |
| Qwen 3.7 Max | A = Grok 4.7 (high) (CON); B = GLM-5.3 (high) (PRO) | Grok 4.7 (high) | -2.0 | -1.70 | 8.0 |

### Judge Notes

- **Kimi K2.6** (A = GLM-5.3 (high) (PRO); B = Grok 4.7 (high) (CON)): A won by cleanly resolving the decisive technical clash over fairness benchmarks. When B argued that conflicting fairness definitions make public benchmarks unworkable, A showed that plural "benchmarks" imply stratified subgroup performance floors across populations rather than a single parity formula, neutralizing B's strongest objection. A sustained a coherent daylight-vs-opacity frame throughout, absorbed the textual concession on "permit" effectively by comparing it to drug licensing, and crystallized the debate around who bears the risk of unmeasured tools. B's license-vs-evidence distinction and midnight-charting harm remained live but were not enough to overcome the collapsed fairness attack and A's sharper narrative progression.
  Most decisive rebuttal noted: A's stratified subgroup floors response dissolved B's "impossible fairness criteria" objection by showing that "bias benchmarks" means performance floors across subgroups, not a single parity formula, leaving B's technical attack without a target in later rounds.
- **Muse Spark 1.1 (high)** (A = Grok 4.7 (high) (CON); B = GLM-5.3 (high) (PRO)): CON won the "only if = permit" clash. PRO misread the motion as reimbursement-only [B2.4], CON exposed it [A2.1][A3.1] forcing a concession [B4.1] that turned midnight-charting delay into a live harm. CON distinguished disclosure from clearance with a clear mechanism — payer can use closed, rotating cases on edited charts vs public leaderboard teaching-to-test [A4.1-A4.4] — which answered PRO's pressure and left PRO's subgroup-floor fix without an account of who sets the veto.
  Most decisive rebuttal noted: A's Rebuttal 1 + Pressure Q1 exposing B's rewrite of "permit and reimburse only if" as reimbursement-only, then A4.1-A4.3 showing private audit is less gameable because items stay closed while public benchmarks must be public and gameable.
- **Qwen 3.7 Max** (A = Grok 4.7 (high) (CON); B = GLM-5.3 (high) (PRO)): Side A won by sharply distinguishing between public benchmarks (which invite gaming and act as a rigid veto) and private payer audits (which evaluate actual human-in-the-loop outcomes). Side A also successfully caught Side B misreading the motion's "permit" condition, forcing a costly concession that the policy would indeed block deployment of unbenchmarked tools. Side A effectively framed this as a harmful delay given the lack of settled benchmark regimes, ultimately proving that the motion demands an "unsettled pass-fail" rather than true accountability.
  Most decisive rebuttal noted: Side A's Rebuttal 2 (A4.1-A4.4), where they brilliantly answered the pressure questions by explaining why private audits are less gameable (using unseen, rotating cases) than public benchmarks (visible hurdles that invite teaching to the test), and clearly distinguished between gathering "evidence" and issuing a "license."

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0624__grok-4.7-high__glm-5-3-high__s1__tpl_placement_active_20260813a.md)
- Roles: PRO = **Grok 4.7 (high)**, CON = **GLM-5.3 (high)**
- Judged result: Unanimous `3-0` for **GLM-5.3 (high)**.
- Entertainment scores: `8`, `7`, `8`
- Mean signed raw margin (PRO+): `-1.37`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Kimi K2.6 | A = Grok 4.7 (high) (PRO); B = GLM-5.3 (high) (CON) | GLM-5.3 (high) | -1.2 | -1.36 | 8.0 |
| Muse Spark 1.1 (high) | A = GLM-5.3 (high) (CON); B = Grok 4.7 (high) (PRO) | GLM-5.3 (high) | -1.4 | -1.49 | 7.0 |
| Qwen 3.7 Max | A = GLM-5.3 (high) (CON); B = Grok 4.7 (high) (PRO) | GLM-5.3 (high) | -1.5 | -1.27 | 8.0 |

### Judge Notes

- **Kimi K2.6** (A = Grok 4.7 (high) (PRO); B = GLM-5.3 (high) (CON)): Side B won by exposing two damaging concessions in Side A's answers to pressure questions: first, that payment would be categorically banned for years when no public benchmark yet exists, extracting a clear patient-harm cost; second, that local pilots can still block a tool even after it clears the public floor, making the benchmark redundant where real safety work happens. B's "incumbent protection" frame and "enforcement theater" crystallization sharpened the comparative harm, while A's structural arguments about vendor capture and scale never fully recovered from the practical asymmetry that the gate blocks new AI tools while entrenched, unbenchmarked human processes continue. A maintained discipline on "necessary not sufficient," but B made that distinction look like a liability rather than a defense.
  Most decisive rebuttal noted: Side B's Rebuttal 2 (B4.4-B4.6), where B converted Side A's direct answers to the pressure questions into the decisive concessions that the rule bans beneficial tools for years despite strong local evidence and that local validation does the actual safety work, rendering the public benchmark "redundant where local evidence exists, and catastrophic where it does not."
- **Muse Spark 1.1 (high)** (A = GLM-5.3 (high) (CON); B = Grok 4.7 (high) (PRO)): Side A (CON) kept the clash on what actually protects patients. After Pressure Questions, Side B conceded the gate bans any tool until a public benchmark exists [B4.1] and still requires local blocking when the floor is met [B4.3]. A turned those into a decisive weigh: redundant where local validation works, and a multi-year block where it doesn't, while leaving entrenched copy-forward error unaddressed. B's public-accountability and bias-visibility case was plausible but never answered the asymmetry cost, transferability problem, or delay burden, despite A directly answering who beyond the vendor can certify local evidence.
  Most decisive rebuttal noted: A's Rebuttal 2 opening with A1:/A2: exposed B's two concessions — categorical ban until benchmarks exist and local pilots doing all real safety work — framing the public bar as enforcement theater that taxes patients with delay.
- **Qwen 3.7 Max** (A = GLM-5.3 (high) (CON); B = Grok 4.7 (high) (PRO)): Side A won by setting a decisive logical trap in Rebuttal 2: if local validation blocks a tool that passes the public floor, the floor is redundant; if the floor blocks a tool with strong local evidence because no public benchmark exists yet, it causes harmful delays. Side B's defense that local pilots don't justify system-wide reimbursement was strong, but Side A effectively countered that existing payer and institutional coverage processes already authorize system-wide use without public benchmarks. Despite Side A being clipped in the first two speeches, its later crystallization of the clash was devastating and rhetorically superior.
  Most decisive rebuttal noted: Side A's Rebuttal 2, which perfectly crystallized the redundancy/delay trap based on Side B's Pressure Question answers, proving the public gate is either enforcement theater or a patient-harm tax.

## Technical metadata

- Evaluation scope: `judge_judge_blend_20260923_finala__debate_all_templates`
- Topic ID: `prop_0624`
- Side-swap group ID: `prop_0624__glm-5-3-high__grok-4.7-high__tpl_placement_active_20260813a`
- Raw paired winner: **Tie**
- Mean normalized margin for GLM-5.3 (high): `+0.42`
- Complete side swap: `yes`
- Included in ratings: `yes`
